Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial. - Bolli R; Perin EC; Willerson JT; Yang PC; Traverse JH; Henry TD; Pepine CJ; Mitrani RD; Hare JM; Murphy MP; March KL; Ikram S; et al. (JACC. CardioOncology, 2020)